Advance nutrition science and technology, deliver value to health

Sirio Pharma Co., Ltd. (SIRIO), founded in 1993, was listed on the Shenzhen Stock Exchange in 2019 (stock code: 300791.SZ). After over 30 years of rapid growth, SIRIO has emerged as a globally recognized contract development and manufacturing organization (CDMO) in the nutraceutical industry, offering an end-to-end solutions, from research and product development to manufacturing, packaging, logistics, and marketing support.
SIRIO is committed to serving clients and consumers worldwide, operating seven automated production bases and five R&D centers across the globe. Through strategic partnerships with leading domestic and international enterprises, the company has positioned itself as one of the most influential players in the industry.